Isopure’s premium brand complements the portfolio of Glanbia’s Global Performance Nutrition (GPN) business and the acquisition further consolidates GPN’s market position. The acquisition is expected to be earnings accretive from 2015 and will be funded from the group’s existing debt facilities.
It is anticipated that the transaction will complete in the fourth quarter of 2014 subject to customary completion conditions and regulatory approval.
Siobhán Talbot, group managing director said, “We are delighted to announce the acquisition of Isopure. As a premium brand, the business is an excellent addition to our portfolio of market leading performance nutrition brands and provides an opportunity to leverage our infrastructure and capabilities to drive future growth. The transaction, which is firmly aligned with the group’s strategy, supports our growth ambitions and will be value enhancing for our shareholders.”